These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36691209)

  • 1. Home-based hepatitis C self-testing in people who inject drugs and men who have sex with men in Georgia: a protocol for a randomised controlled trial.
    Shilton S; Stvilia K; Japaridze M; Tsereteli N; Usharidze D; Phevadze S; Jghenti M; Mozalevskis A; Markby J; Luhmann N; Johnson C; Nabeta P; Ongarello S; Reipold EI; Gamkrelidze A
    BMJ Open; 2022 Sep; 12(9):e056243. PubMed ID: 36691209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usability and acceptability of oral-based HCV self-testing among key populations: a mixed-methods evaluation in Tbilisi, Georgia.
    Fajardo E; Watson V; Kumwenda M; Usharidze D; Gogochashvili S; Kakhaberi D; Giguashvili A; Johnson CC; Jamil MS; Dacombe R; Stvilia K; Easterbrook P; Ivanova Reipold E
    BMC Infect Dis; 2022 May; 22(1):510. PubMed ID: 35641908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A quasi-randomised controlled trial of online distribution of home-based hepatitis C self-testing for key populations in Malaysia: a study protocol.
    Shilton S; Sem X; Chan HK; Chung HY; Karunanithy A; Markby J; Chan PL; Luhmann N; Johnson C; Nabeta P; Nasir NHB; Ongarello S; Reipold EI; Hassan MRA
    Trials; 2022 Apr; 23(1):304. PubMed ID: 35413933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceptability and usability of oral fluid HCV self-testing for hepatitis C diagnosis: A systematic review and meta-analysis.
    Perazzo H; Castro R; Villela-Nogueira C; Torres M; Silva SL; Cardoso SW; Grinsztejn B; Veloso VG
    J Viral Hepat; 2023 Nov; 30(11):838-847. PubMed ID: 37485619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding hepatitis C virus test uptake using self-testing among men who have sex with men in China: two parallel randomized controlled trials.
    Wang C; Zhao P; Weideman AM; Xu W; Ong JJ; Jamil MS; Yang B; Tucker JD
    BMC Med; 2023 Jul; 21(1):279. PubMed ID: 37507702
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Byrne C; Radley A; Inglis SK; Beer LJZ; Palmer N; Pham MD; Healy B; Doyle JS; Donnan P; Dillon JF
    BMJ Open; 2020 Aug; 10(8):e036501. PubMed ID: 32868356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating HCV testing with HIV programs improves hepatitis C outcomes in people who inject drugs: A cluster-randomized trial.
    Solomon SS; Quinn TC; Solomon S; McFall AM; Srikrishnan AK; Verma V; Kumar MS; Laeyendecker O; Celentano DD; Iqbal SH; Anand S; Vasudevan CK; Saravanan S; Thomas DL; Sachdeva KS; Lucas GM; Mehta SH
    J Hepatol; 2020 Jan; 72(1):67-74. PubMed ID: 31604081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protocol for a cluster randomised controlled trial of secondary distribution of hepatitis C self-testing within the context of a house-to-house hepatitis C micro-elimination programme in Karachi, Pakistan.
    Shilton S; Ali D; Hasnain A; Abid A; Markby J; Jamil MS; Luhmann N; Nabeta P; Ongarello S; Reipold EI; Hamid S
    BMC Public Health; 2022 Apr; 22(1):696. PubMed ID: 35397544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respondent-driven sampling for identification of HIV- and HCV-infected people who inject drugs and men who have sex with men in India: A cross-sectional, community-based analysis.
    Solomon SS; McFall AM; Lucas GM; Srikrishnan AK; Kumar MS; Anand S; Quinn TC; Celentano DD; Mehta SH
    PLoS Med; 2017 Nov; 14(11):e1002460. PubMed ID: 29182638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) - a natural experiment (protocol).
    Hickman M; Dillon JF; Elliott L; De Angelis D; Vickerman P; Foster G; Donnan P; Eriksen A; Flowers P; Goldberg D; Hollingworth W; Ijaz S; Liddell D; Mandal S; Martin N; Beer LJZ; Drysdale K; Fraser H; Glass R; Graham L; Gunson RN; Hamilton E; Harris H; Harris M; Harris R; Heinsbroek E; Hope V; Horwood J; Inglis SK; Innes H; Lane A; Meadows J; McAuley A; Metcalfe C; Migchelsen S; Murray A; Myring G; Palmateer NE; Presanis A; Radley A; Ramsay M; Samartsidis P; Simmons R; Sinka K; Vojt G; Ward Z; Whiteley D; Yeung A; Hutchinson SJ
    BMJ Open; 2019 Sep; 9(9):e029538. PubMed ID: 31551376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. M
    Martel-Laferrière V; Feaster DJ; Metsch LR; Schackman BR; Loignon C; Nosyk B; Tookes H; Behrends CN; Arruda N; Adigun O; Goyer ME; Kolber MA; Mary JF; Rodriguez AE; Yanez IG; Pan Y; Khemiri R; Gooden L; Sako A; Bruneau J
    Trials; 2022 Apr; 23(1):341. PubMed ID: 35461260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Same-visit hepatitis C testing and treatment to accelerate cure among people who inject drugs (the QuickStart Study): a cluster randomised cross-over trial protocol.
    Doyle JS; Heath K; Elsum I; Douglass C; Wade A; Kasza J; Allardice K; Von Bibra S; Chan K; Camesella B; Guzman R; Bryant M; Thompson AJ; Stoové MA; Snelling TL; Scott N; Spelman T; Anderson D; Richmond J; Howell J; Andric N; Dietze PM; Higgs P; Sacks-Davis R; Forbes AB; Hellard ME; Pedrana AE
    BMJ Open; 2024 Jul; 14(7):e083502. PubMed ID: 38960465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usability and acceptability of oral fluid hepatitis C self-testing among people who inject drugs in Coastal Kenya: a cross-sectional pilot study.
    Ivanova Reipold E; Fajardo E; Juma E; Bukusi D; Bermudez Aza E; Jamil MS; Johnson CC; Farquhar C; Easterbrook P; Monroe-Wise A
    BMC Infect Dis; 2022 Sep; 22(1):738. PubMed ID: 36109704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis.
    Cunningham EB; Wheeler A; Hajarizadeh B; French CE; Roche R; Marshall AD; Fontaine G; Conway A; Bajis S; Valencia BM; Presseau J; Ward JW; Degenhardt L; Dore GJ; Hickman M; Vickerman P; Grebely J
    Int J Drug Policy; 2023 Jan; 111():103917. PubMed ID: 36542883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C treatment uptake among patients who have received methadone substitution treatment in the Republic of Georgia.
    Stvilia K; Vephkvadze N; Gamkrelidze A; Khonelidze I; Getia V; Tsereteli M; Gvinjilia L; Kuchuloria T
    Public Health; 2021 Jun; 195():42-50. PubMed ID: 34051674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Values and preferences for hepatitis C self-testing among people who inject drugs in Kyrgyzstan.
    Martínez-Pérez GZ; Nikitin DS; Bessonova A; Fajardo E; Bessonov S; Shilton S
    BMC Infect Dis; 2021 Jun; 21(1):609. PubMed ID: 34171990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does a simplified algorithm and integrated HCV care model improve linkage to care, retention, and cure among people who inject drugs? A pragmatic quality improvement randomized controlled trial protocol.
    Klaman SL; Godino JG; Northrup A; Lewis SV; Tam A; Carrillo C; Lewis R; Matthews E; Mendez B; Reyes L; Rojas S; Ramers C
    BMC Infect Dis; 2024 Jan; 24(1):105. PubMed ID: 38238686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards HCV elimination among people who inject drugs in Hai Phong, Vietnam: study protocol for an effectiveness-implementation trial evaluating an integrated model of HCV care (DRIVE-C: DRug use & Infections in ViEtnam-hepatitis C).
    Rapoud D; Quillet C; Pham Minh K; Vu Hai V; Nguyen Thanh B; Nham Thi Tuyet T; Tran Thi H; Molès JP; Vallo R; Michel L; Feelemyer J; Weiss L; Lemoine M; Vickerman P; Fraser H; Duong Thi H; Khuat Thi Hai O; Des Jarlais D; Nagot N; Laureillard D;
    BMJ Open; 2020 Nov; 10(11):e039234. PubMed ID: 33208326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptability of on-site rapid HIV/HBV/HCV testing and HBV vaccination among three at-risk populations in distinct community-healthcare outreach centres: the ANRS-SHS 154 CUBE study.
    Calin R; Massari V; Pialoux G; Reydellet N; Plenel E; Chauvin C; Jauffret-Roustide M; Day N; Kreplak G; Maresca AF; Derche N; Louis S; Pol S; Doré V; Rouzioux C; Chauvin P
    BMC Infect Dis; 2020 Nov; 20(1):851. PubMed ID: 33198672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.